Article Menu

Export Article

More by Authors Links

Article Data

  • Views 202
  • Dowloads 128

This is a correction to: European Journal of Gynaecological Oncology. 2025; 46(3): 74-83. https://doi.org/10.22514/ejgo.2025.038

Corrections

Open Access

Correction: Immunohistochemical expression and predictive value of PAX3 and FOXO1 proteins in high-grade serous ovarian carcinoma

  • Dejan Tirić1,2,*,
  • Dragan Soldo1,2
  • Vajdana Tomić1,2,3
  • Nikolina Penava1,2
  • Kristina Katić4
  • Marija Milković Periša5

1Department of Obstetrics and Gynecology, University Clinical Hospital Mostar, 88000 Mostar, Bosnia and Herzegovina

2Faculty of Medicine, University Mostar, 88000 Mostar, Bosnia and Hercegovina

3Faculty of Health Studies, University Mostar, 88000 Mostar, Bosnia and Hercegovina

4Department of Obstetrics and Gynecology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia

5School of Medicine, University of Zagreb, 10000 Zagreb, Croatia

DOI: 10.22514/ejgo.2026.055 Vol.47,Issue 3,October 2026 pp.158-158

Published: 15 October 2026

*Corresponding Author(s): Dejan Tirić E-mail: dejan.tiric@mef.sum.ba

PDF (233.46 kB) View Full-text

Cite and Share

Dejan Tirić, Dragan Soldo, Vajdana Tomić, Nikolina Penava, Kristina Katić, Marija Milković Periša. Correction: Immunohistochemical expression and predictive value of PAX3 and FOXO1 proteins in high-grade serous ovarian carcinoma. European Journal of Gynaecological Oncology. 2026; 47(3): 158-158. doi: 10.22514/ejgo.2026.055

URL:

https://www.ejgo.net/articles/10.22514/ejgo.2026.055

References

[1] Tirić D, Soldo D, Tomić V, Penava N, Katić K, Milković Periša M. Immunohistochemical expression and predictive value of PAX3 and FOXO1 proteins in high-grade serous ovarian carcinoma. European Journal of Gynaecological Oncology. 2025; 46: 74–83.

Submission Turnaround Time

Top